85-1563-08　Sunitinib, Free Base 200mg　CAS No:557795-19-4　S8031-97

特徴

• Sunitinib (as the malate salt) is the active ingredient in the drug sold under the trade name Sutent. This drug is a small molecule receptor tyrosine kinase inhibitor that has been approved in at least one country for the treatment of patients having gastrointestinal stromal tumors or renal cell carcinomas.
• Synonyms:N-[2-(Diethylamino)ethyl]-5-[(Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide; SU-11248; Sutent; PHA-290940AD; PNU-290940AD
• Molecular Formula:C22H27FN4O2
• Molecular Weight:398.47
• Appearance:Yellow powder
• Purity:≥99% (HPLC, TLC)
• Solubility:Soluble in DMSO at 40mg/ml; soluble in ethanol at 1.4mg/ml with warming; very poorly soluble in water; maximum solubility in plain water is estimated to be about 10-20uM; buffers, serum, or other additives may increase or decrease the aqueous solubility.
• Elemental Analysis Calculated:%C: 66.31%H: 6.83%F: 4.77%N: 14.06
• Storage and Stability:Lyophilized and reconstituted products are stable for 6 months after receipt at -20°C. Reconstitute with DMSO or EtOH. Aliquot to avoid repeated freezing and thawing. Store at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.